Achr Ab Seropositive Generalized Myasthenia Gravis clinical trials

Explore recruiting achr ab seropositive generalized myasthenia gravis clinical trials.

Recruiting achr ab seropositive generalized myasthenia gravis studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Achr Ab Seropositive Generalized Myasthenia Gravis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Master Protocol Full Title: A Master Protocol for an Exploratory, Phase 2a, Proof-of-Concept Platform Study to Evaluate the Safety, Tolerability, and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis. ISA 1 Full Title: An ISA to Master Protocol ARGX-999-2-MG-2000 for an Exploratory, Phase 2a, Proof-of-Concept Study to Evaluate the Safety, Tolerability, and Efficacy of Empasiprubart IV as Add-On Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod.

Spain, Poland, Germany, Netherlands, Greece, Italy +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Master Protocol Full Title- A Master Protocol for an Exploratory, Phase 2a, Proof-of-Concept Platform Study to Evaluate the Safety, Tolerability, and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis. ISA 2 to Master Protocol ARGX-999-2-MG-2000 – an Exploratory, Phase 2a, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis

Greece, Italy, Germany, Belgium, Netherlands, Spain +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Achr Ab Seropositive Generalized Myasthenia Gravis trials by city

Achr Ab Seropositive Generalized Myasthenia Gravis in Toronto Achr Ab Seropositive Generalized Myasthenia Gravis in Vancouver Achr Ab Seropositive Generalized Myasthenia Gravis in Montreal Achr Ab Seropositive Generalized Myasthenia Gravis in Calgary Achr Ab Seropositive Generalized Myasthenia Gravis in Edmonton Achr Ab Seropositive Generalized Myasthenia Gravis in Ottawa Achr Ab Seropositive Generalized Myasthenia Gravis in Winnipeg Achr Ab Seropositive Generalized Myasthenia Gravis in Quebec City Achr Ab Seropositive Generalized Myasthenia Gravis in Hamilton Achr Ab Seropositive Generalized Myasthenia Gravis in Kitchener Achr Ab Seropositive Generalized Myasthenia Gravis in London Achr Ab Seropositive Generalized Myasthenia Gravis in Halifax Achr Ab Seropositive Generalized Myasthenia Gravis in New York Achr Ab Seropositive Generalized Myasthenia Gravis in Los Angeles Achr Ab Seropositive Generalized Myasthenia Gravis in Chicago Achr Ab Seropositive Generalized Myasthenia Gravis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease